From Late Line Success to Earlier Line Use: Redefining Radiopharmaceuticals as Transformative Frontline Cancer Therapies to Maximise Long-Term Patient Benefit & Disease Control

From Late Line Success to Earlier Line Use: Redefining Radiopharmaceuticals as Transformative Frontline Cancer Therapies to Maximise Long-Term Patient Benefit & Disease Control

3:59 pm - Wednesday 2nd December 2026